In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials.
Download this new guide from SGS to discover:
- How to collaborate in the fast-paced world of drug development
- The current challenges of working with different CDMOs and CROs
- A pathway built to bring drug development consultancy, bioanalysis, formulation and manufacturing, and clinical research services into one programme
- How do SGS PACE regulatory consultancy services factor into the mix?